Training activity information
Details
Present a case report of a patient undergoing novel therapy as part of a clinical trial
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Clinical trial protocol
- Comparison of novel treatment and current standard care
- Trial eligibility
- Consent processes
- Supportive care recommendations
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the key learning points you want to convey through this case presentation? What is the purpose of presenting such cases?
- What was the patient’s diagnosis and treatment history? What is the novel therapy they are receiving and what is the rationale for its use in this clinical trial?
- What were the key findings and outcomes for this patient during the trial? What is the expected audience and format for the presentation?
- Will you obtain the necessary information and approvals regarding the patient’s case? Will you structure your presentation logically, highlighting the key aspects of the case?
- Will you practice your delivery and anticipate potential questions? What challenges might you face in presenting sensitive or complex clinical trial data? How do you feel about presenting to an audience?
In action
- As you deliver the presentation, how are you monitoring the audience’s understanding and adjusting your explanation as needed? Are you speaking clearly and concisely?
- When asked questions about the case or the novel therapy, how are you formulating your responses based on your current understanding?
- Are you finding it easier to explain certain aspects of the case compared to the details of the novel therapy or the clinical trial design? Why might this be?
- What challenges are you facing (e.g., technical difficulties, unexpected questions)? How are you adapting to these challenges during the presentation?
- What are you learning about presenting complex clinical information and responding to questions in real-time?
- If you are unsure about an answer to a question, are you considering how to acknowledge this and offer to follow up?
On action
- Summarise the key aspects of the case you presented, including the patient’s diagnosis, the novel therapy they received as part of the clinical trial, and the outcomes observed.
- How did the audience respond to your presentation?
- What did you learn about effectively communicating complex clinical information, particularly regarding novel therapies and clinical trials, to an audience?
- What aspects of your presentation were particularly well-received or challenging to explain?
- Were there any unexpected questions or areas of interest raised by the audience?
- How did you handle these in the moment, and what did you learn from their queries?
- Thinking about your delivery and the information you shared, how did your real-time adjustments to your explanation or responses impact the audience’s understanding?
- How important are strong presentation skills for effectively disseminating information about novel therapies and clinical trial findings within the healthcare community?
- What specific aspects of your presentation skills (e.g., clarity, conciseness, visual aids, responding to questions) do you want to improve?
- How will this experience influence your approach to preparing and delivering future clinical presentations?
- What are your next steps in terms of seeking feedback on your presentation or practicing your communication skills further?
- Do you need any further resources or training on effective presentation techniques or communicating scientific information?
Beyond action
- Have you prepared or presented other case reports, especially those involving novel therapies within the scope of advanced therapies and stem cells, since this training activity? How did your presentation style or focus evolve?
- Have you reviewed your initial reflect-on-action notes from this presentation? What aspects of presenting such a case do you now view differently?
- Can you recall discussions or situations where your understanding of novel therapies and clinical trials in haematological disorders was relevant?
- Has this training activity improved your ability to synthesise complex information about novel therapies and clinical trials and present it effectively?
- Do you feel more confident in communicating the laboratory findings related to patients on clinical trials involving advanced therapies to a wider audience?
- Has preparing this case report enhanced your understanding of the integration of laboratory data within the context of clinical research and novel treatments for haematological conditions?
- Have the skills in information gathering, critical analysis, and presentation developed through this activity been transferable to other areas of your professional practice?
- How will your experience in preparing and presenting case reports on novel therapies be valuable in future educational or professional settings, such as multidisciplinary team meetings or scientific conferences focused on advanced therapies and stem cells?
- Will your understanding of the complexities of novel therapies and clinical trials contribute to your ability to work effectively in research-oriented environments?
- How might this experience inform your future development in areas such as translational medicine or the implementation of new therapeutic strategies?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Practice in accordance with legislation regarding use of human tissue. |
| # 3 |
Outcome
Appraise the application of novel and evolving therapies in the treatment of haematological conditions. |